Investments
21Portfolio Exits
3Funds
6Partners & Customers
3About Columbus Venture Partners
Columbus Venture Partner (CVP) is an independent venture capital that brings a unique approach for investing in outstanding early-stage and high growth opportunities in the life science industry in Spain. CVP portfolio is mainly invested in the Spanish market through its fund Columbus INNVIERTE Life Sciences FCR, in which the Spanish government participates through CDTI.
Want to inform investors similar to Columbus Venture Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Columbus Venture Partners News
May 10, 2023
RocaJunyent advises Arthex Biotech on the closing of a €42m financing round RocaJunyent has advised Arthex Biotech on the closing of a €42m Series B financing round. The round was led by Columbus Venture Partners and also had participation from the European Innovation Council (EIC), Hadean Ventures, Sound Bioventures and previous investors Invivo Capital, AdBio Partners and CDTI. The team from RocaJunyent advising on this deal was formed by the partner, Xavier Foz Giralt, together with the senior associate, Jordi Bermúdez Gutiérrez. iberianlawyer.com Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store. In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors. For further information, please visit the Group’s website www.lcpublishinggroup.com
Columbus Venture Partners Investments
21 Investments
Columbus Venture Partners has made 21 investments. Their latest investment was in Arthex Biotech as part of their Series B on May 5, 2023.
Columbus Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/3/2023 | Series B | Arthex Biotech | $46.25M | Yes | 5 | |
3/14/2023 | Series A | Cocoon Bioscience | $15.9M | Yes | Capital Riesgo del Pais Vasco, Cleon Capital, Columbus Venture Partners, North South Ventures, Sangha Capital, Undisclosed Investors, and Viscofan | 4 |
11/29/2022 | Seed VC | Jurata Thin Film | $4.87M | Yes | 3 | |
5/31/2022 | Series C | |||||
3/29/2022 | Seed VC - II |
Date | 5/3/2023 | 3/14/2023 | 11/29/2022 | 5/31/2022 | 3/29/2022 |
|---|---|---|---|---|---|
Round | Series B | Series A | Seed VC | Series C | Seed VC - II |
Company | Arthex Biotech | Cocoon Bioscience | Jurata Thin Film | ||
Amount | $46.25M | $15.9M | $4.87M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Capital Riesgo del Pais Vasco, Cleon Capital, Columbus Venture Partners, North South Ventures, Sangha Capital, Undisclosed Investors, and Viscofan | ||||
Sources | 5 | 4 | 3 |
Columbus Venture Partners Portfolio Exits
3 Portfolio Exits
Columbus Venture Partners has 3 portfolio exits. Their latest portfolio exit was Sanifit on November 22, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/22/2021 | Acquired | 6 | |||
Date | 11/22/2021 | ||
|---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 6 |
Columbus Venture Partners Fund History
6 Fund Histories
Columbus Venture Partners has 6 funds, including Columbus Life Sciences Fund III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/26/2021 | Columbus Life Sciences Fund III | $144.99M | 2 | ||
9/23/2019 | Columbus Life Science Fund II | ||||
12/31/2016 | Columbus INNVIERTE Life Sciences | ||||
Columbus Venture Partners | |||||
Columbus Life Sciences Fund IV |
Closing Date | 4/26/2021 | 9/23/2019 | 12/31/2016 | ||
|---|---|---|---|---|---|
Fund | Columbus Life Sciences Fund III | Columbus Life Science Fund II | Columbus INNVIERTE Life Sciences | Columbus Venture Partners | Columbus Life Sciences Fund IV |
Fund Type | |||||
Status | |||||
Amount | $144.99M | ||||
Sources | 2 |
Columbus Venture Partners Partners & Customers
3 Partners and customers
Columbus Venture Partners has 3 strategic partners and customers. Columbus Venture Partners recently partnered with AskBio on January 1, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
1/9/2023 | Partner | United States | 4 | ||
10/17/2017 | Partner | ||||
10/17/2017 | Partner |
Date | 1/9/2023 | 10/17/2017 | 10/17/2017 |
|---|---|---|---|
Type | Partner | Partner | Partner |
Business Partner | |||
Country | United States | ||
News Snippet | |||
Sources | 4 |
Columbus Venture Partners Team
3 Team Members
Columbus Venture Partners has 3 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Javier Garcia | Founder | Current | |
Name | Javier Garcia | ||
|---|---|---|---|
Work History | |||
Title | Founder | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.